Tevogen Announces Formation of a Healthcare Services Initiative

Tevogen's new Healthcare Services Initiative marks the company's pivot toward building a broader, revenue-generating healthcare platform. The announcement, issued from Warren, New Jersey on June 9, 2026, states the initiative will be led on an interim basis by William Keane, Tevogen's Vice President of Strategic Initiatives. The venture may include potential acquisitions of a Management Services Organization and a Contract Research Organization, if consummated. Management says the opportunities could yield approximately $100 million in combined annual revenue, supporting Tevogen's mission to improve affordability and access across healthcare. Chief Financial Officer Kirti Desai underscored a disciplined approach to strategic fit, long-term value creation, and stewardship of the company's capital. Beyond the targeted acquisitions, Tevogen describes the healthcare services initiative as a complement to its biotechnology and artificial intelligence programs by expanding potential infrastructure capabilities and growth opportunities. Any acquisition decisions will be guided by strategic fit and long-term value creation, with capital deployment disciplined to support the core business. The company says Tevogen Bio remains central, combining its ExacTcell platform with broader healthcare initiatives to drive scalable solutions. The announcement emphasizes the company's broader mission of affordability and access while pursuing revenue-generating opportunities to strengthen financial self-sufficiency.